University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor

Peter V. Chin-Hong, M.D.

Infectious disease specialist

Dr. Peter Chin-Hong specializes in treating infectious diseases, particularly infections that develop in patients who have suppressed immune systems, such as solid organ and hematopoietic stem cell transplant recipients and HIV+ organ transplant recipients. His research focuses on human papillomavirus, Chagas disease and viral and fungal infections in patients with suppressed immune systems. His work on the subject has been published in numerous journals and books.

Chin-Hong earned his undergraduate and medical degrees from Brown University, before completing an internal medicine residency and infectious diseases fellowship at UCSF, where he is an associate professor of clinical medicine and associate director of the CTSI Predoctoral Research Fellowship Programs. Chin-Hong is the recipient of numerous prestigious UCSF awards, including the Excellence in Direct Teaching and Core Curriculum Distinction in Teaching Award. He is a member of the Infectious Diseases Society of America, American Society of Microbiology and American Society of Transplantation.

Clinics

Infectious Disease at Parnassus
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143-0327
Phone: (415) 353-2626
Fax: (415) 353-2568

Hours: Thursday
8:20 – 11:40 a.m.

More about Peter V. Chin-Hong

Education

Brown University School of Medicine 1997

Residencies

UCSF Medical Center 2000

Fellowships

UCSF Medical Center 2002

Selected Research and Publications

  1. Hickey MD, Quan DJ, Chin-Hong PV, Roberts JP. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation. Liver Transpl. 2013 Apr; 19(4):457-61.
  2. Chin-Hong PV, Kwak EJ. Human papillomavirus in solid organ transplantation. Am J Transplant. 2013 Mar; 13 Suppl 4:189-200.
  3. Chin-Hong PV, Roland M, Stock P, Beatty G. . Clin Infect Dis. Organ Transplantation in HIV-infected individuals. 2013; in pr..
  4. Spellberg B, Kontoyiannis DP, Fredricks D, Morris MI, Perfect JR, Chin-Hong PV, Ibrahim AS, Brass EP. Risk factors for mortality in patients with mucormycosis. Med Mycol. 2012 Aug; 50(6):611-8.
  5. Wiita AP, Roubinian N, Khan Y, Chin-Hong PV, Singer JP, Golden JA, Miller S. Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis. Transpl Infect Dis. 2012 Jun; 14(3):248-58.
  6. Spellberg B, Ibrahim AS, Chin-Hong PV, Kontoyiannis DP, Morris MI, Perfect JR, Fredricks D, Brass EP. The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother. 2012 Mar; 67(3):715-22.
  7. Shubov A, Jagannathan P, Chin-Hong PV. Pantoea agglomerans pneumonia in a heart-lung transplant recipient: case report and a review of an emerging pathogen in immunocompromised hosts. Transpl Infect Dis. 2011 Oct; 13(5):536-9.
  8. Schwartz BS, Paster M, Ison MG, Chin-Hong PV. Organ donor screening practices for Trypanosoma cruzi infection among US Organ Procurement Organizations. Am J Transplant. 2011 Apr; 11(4):848-51.
  9. Chin-Hong PV, Schwartz BS, Bern C, Montgomery SP, Kontak S, Kubak B, Morris MI, Nowicki M, Wright C, Ison MG. Screening and treatment of chagas disease in organ transplant recipients in the United States: recommendations from the chagas in transplant working group. Am J Transplant. 2011 Apr; 11(4):672-80.
  10. Liu C, Schwartz BS, Vallabhaneni S, Nixon M, Chin-Hong PV, Miller SA, Chiu C, Damon L, Drew WL. Pandemic (H1N1) 2009 infection in patients with hematologic malignancy. Emerg Infect Dis. 2010 Dec; 16(12):1910-7.
  11. Chin-Hong PV, Husnik M, Cranston RD, Colfax G, Buchbinder S, Da Costa M, Darragh T, Jones D, Judson F, Koblin B, Mayer KH, Palefsky JM. Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS. 2009 Jun 1; 23(9):1135-42.
  12. Berry JM, Palefsky JM, Jay N, Cheng SC, Darragh TM, Chin-Hong PV. Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia. Dis Colon Rectum. 2009 Feb; 52(2):239-47.
  13. Chin-Hong PV, Klausner JD. New diagnostic tests for HPV in the developed and the developing world. MLO Med Lab Obs. 2008 Nov; 40(11):48, 50, 52-3.
  14. Chin-Hong PV, Berry JM, Cheng SC, Catania JA, Da Costa M, Darragh TM, Fishman F, Jay N, Pollack LM, Palefsky JM. Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men. Ann Intern Med. 2008 Sep 2; 149(5):300-6.
  15. Guimarães MD, Grinsztejn B, Chin-Hong PV, Campos LN, Gomes VR, Melo VH, Pilotto JH, Carmo RA, Palefsky JM. Behavior surveillance: prevalence and factors associated with high-risk sexual behavior among HIV-infected men in Brazil in the post-HAART era. AIDS Behav. 2008 Sep; 12(5):741-7.
  16. Chin-Hong PV. Cutting human papillomavirus infection in men. J Infect Dis. 2008 Mar 15; 197(6):781-3.
  17. Graber CJ, Lauring AS, Chin-Hong PV. Clinical problem-solving. A stitch in time--a 64-year-old man with a history of coronary artery disease and peripheral vascular disease was admitted to the hospital with a several-month history of fevers, chills, and fatigue. N Engl J Med. 2007 Sep 6; 357(10):1029-34.
  18. Chin-Hong PV, Hecht FM, Klausner JD. Newly diagnosed HIV infection. N Engl J Med. 2006 Feb 16; 354(7):771-2; author reply 771-2.
  19. Chin-Hong PV. Johns Hopkins Advanced Studies in Medicine. Infections in Patients With Diabetes Mellitus: Importance of Early Recognition, Treatment, and Prevention. 2006; 6(2):71-81.
  20. Chin-Hong PV, Deeks SG, Liegler T, Hagos E, Krone MR, Grant RM, Martin JN. High-risk sexual behavior in adults with genotypically proven antiretroviral-resistant HIV infection. J Acquir Immune Defic Syndr. 2005 Dec 1; 40(4):463-71.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.